The development of NAFLD in liver-specific JAK2-deficient (JAK2L) [154] and liver-specific STAT5-deficient mice [155] highlights the importance of the GH signaling pathway. Here, GH1 is linked to metabolic dysfunction-associated steatotic liver disease.